MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from related party loan...
Stock-based compensation
Accounts payable
Others
Negative Cash Flow Breakdown
Net loss
Repayment of promissory notes
Other assets
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-4,347
-4,576
-6,158
-154,258
Stock-based compensation
1,295
1,484
2,032
140,403
Interest accrued on promissory notes
123
-
-
-
Prepaid expenses
-13
540
576
10
Other assets
51
-
0
-9,851
Accounts payable
495
511
1,624
521
Accrued expenses
334
451
-527
1,231
Net cash used in operating activities
-2,138
-2,670
-3,605
-2,262
Proceeds from business combination
-
-
1
26
Repayment of promissory notes
660
750
-
-
Proceeds from related party loans
2,734
3,503
-4,063
9,911
Payments of deferred offering costs
0
-7,602
-
7,602
Net cash provided by financing activities
2,074
2,753
3,540
2,335
Net change in cash and cash equivalents
-64
83
-65
73
Cash and cash equivalents at beginning of period
103
20
85
12
Cash and cash equivalents at end of period
39
103
20
85
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from related
party loans
$2,734K
Net cash provided by
financing activities
$2,074K
Canceled cashflow
$660K
Net change in cash
and cash...
-$64K
Canceled cashflow
$2,074K
Stock-based compensation
$1,295K
Accounts payable
$495K
Accrued expenses
$334K
Interest accrued on
promissory notes
$123K
Prepaid expenses
-$13K
Repayment of promissory
notes
$660K
Net cash used in
operating activities
-$2,138K
Canceled cashflow
$2,260K
Net loss
-$4,347K
Other assets
$51K
Buy us a coffee
Semnur Pharmaceuticals, Inc. (SMNR)
Semnur Pharmaceuticals, Inc. (SMNR)